PREVENTIVE AND/OR THERAPEUTIC AGENT FOR THROMBOEMBOLISM IN THROMBOEMBOLISM PATIENT WITH SEVERE RENAL IMPAIRMENT

• 1. 用于具有重度肾损害的血栓栓塞患者中血栓栓塞的预防和/或治疗剂 [P] . 中国专利： CN103987389A . 2014-08-13
• 2. 用于治疗和/或预防血栓形成性或血栓栓塞性疾病和/或血栓形成性或血栓栓塞性并发症的取代的氧代吡啶衍生物 [P] . 中国专利： CN113166099A . 2021-07-23
• 3. Preventive And/Or Therapeutic Agent For Thromboembolism In Thromboembolism Patient With Severe Renal Impairment [P] . 美国专利： US2014100244A1 . 2014-04-10

  机译： 严重肾功能不全的血栓栓塞患者的血栓栓塞预防和/或治疗药物

• 4. PREVENTIVE AND/OR THERAPEUTIC AGENT FOR THROMBOEMBOLISM IN THROMBOEMBOLISM PATIENT WITH SEVERE RENAL IMPAIRMENT [P] . 美国专利： US2013158069A1 . 2013-06-20

  机译： 患有严重肾功能不全的血栓栓塞患者的血栓栓塞症预防和/或治疗剂

• 5. THROMBOEMBOLISM PREVENTIVE/THERAPEUTIC AGENT FOR THROMBOEMBOLISM PATIENTS HAVING SEVERE RENAL DYSFUNCTION [P] . 欧洲知识产权局专利： EP2792357A4 . 2015-05-20

  机译： 患有严重肾功能不全的血栓栓塞症患者的血栓栓塞症预防/治疗剂

• 1. The Therapeutic Effectiveness of Hybrid Renal Replacement (HRRT) in Patients with Severe Snakebite [J] . HU Shou-liang, CHENG Jun-zhang, LU Hong-zhu, 中国生物医学工程学报（英文版） . 2012,第002期
• 2. Venous Thromboembolism and Renal Impairment: Insights from the SWIss Venous ThromboEmbolism Registry (SWIVTER) [J] . Spirk David, Sebastian Tim, Banyai Martin, Seminars in Thrombosis and Hemostasis . 2019,第8期
• 3. Newer Oral Anticoagulants Should Be Used as First-Line Agents to Prevent Thromboembolism in Patients with Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism [J] . Circulation: An Official Journal of the American Heart Association . 2012,第1期
• 4. Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery: A real-world, prospective, multicentre, cohort study [J] . MismettiP., SamamaC.-M., RosencherN., Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 2012,第6期
• 5. Antiplatelet Agents for Prewention of Thromboembolism in Atrial Fibrillation: When, Why, and Which One? [C] . G. Di Pasquale, E. Cere, S. Biancoli, International Workshop on Cardiac Arrhythmias . 2002
• 6. Venous Thromboembolism Risk Assessment in Renal Transplant Patients at the Queen's Medical Center in Hawai'i [D] . Hironaka, Ryan K. 2018
• 7. Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence incidence and risk factors [O] . Deborah Cook, James Douketis, Maureen Meade, 2008
• 8. Evaluation of preventive methods for the symptomatic pulmonary thromboembolism by postoperative anticoagulant therapy in venous thromboembolism high risk patients with gynecologic malignancy [O] . Manabu SEINO, Toshifumi TAKAHASHI, Hirohisa KURACHI 2012

• 1. Application and Reliability of Caprini Thrombus Risk Assessment Scale in Risk Assessment of Venous Thromboembolism in Acute and Severe Uygur Patients [J] . Jinfang Yue ,Lingyun Zuo ,Xiang Si . 临床医学国际期刊（英文） . 2019,第11期
• 2. Eltrombopag-related renal vein thromboembolism in a patient with immune thrombocytopenia: A case report [J] . Cen Wu ,Xiao-Ming Zhou ,Xiao-Dong Liu . 世界临床病例杂志 . 2021,第011期
• 3. Changes in Brachial and Central Blood Pressure after Short Term Continuous Positive Airway Pressure Treatment of Patients with Moderate-to-Severe Obstructive Sleep Apnoea and Impaired Renal Function [J] . Bodil GHornstrup1 ,Pia HGjorup1 ,Jost Wessels1 . 肾脏病（英文） . 2019,第1期
• 4. Antithrombotic Agents in the Prevention and Treatment of Venous Thromboembolism [J] . 包承鑫 . 血栓与止血学 . 2004,第001期
• 5. 重症监护病房患者合并静脉血栓栓塞症的风险与预防 [C] . 李军 ,倪松石 . 2018年中华医学会呼吸病学年会呼吸与危重症医学2017-2018 . 2018
• 6. 手术室护士预防患者术中发生静脉血栓栓塞症的知信行调查及影响因素分析 [A] . 郝敏江 . 2020